PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Nutrients turn on key tumor signaling molecule, fueling resistance to cancer therapy, Ludwig Cancer Research study shows

2015-07-13
(Press-News.org) July 13, 2015, New York -- Tumors can leverage glucose and another nutrient, acetate, to resist targeted therapies directed at specific cellular molecules, according to Ludwig Cancer Research scientists studying glioblastoma, a deadly brain cancer.

The findings, published in the July 13 Proceedings of the National Academy of Sciences, demonstrate that nutrients can strongly affect the signaling molecules that drive tumors. "This study shows that metabolic and nutritional factors might be quite important in cancer development and treatment," says Ludwig San Diego member Paul Mischel, the lead author of the study, and Professor of Pathology at the University of California, San Diego.

The study also highlights one way that tumors can evade targeted drugs such as erlotinib and gefitinib, inhibitors of a mutant form of the cellular molecule EGFR (epidermal growth factor receptor) that drives the growth of many glioblastomas and other tumor types.

Cancer researchers have known for years that tumors have unusual metabolisms - their rapid use of glucose is used as a diagnostic tool for tumors in PET scans. But only recently have scientists begun to flesh out the details of this metabolic shift. Mischel and other researchers have previously shown that this shift can occur through the activation of a central cellular signal, mTORC2 (mTOR complex 2). mTORC2 is involved in switching cancer cells to a hyperactive metabolic state, for instance prompting the increased influx of glucose and acetate into cancer cells. Glucose and acetate provide fuel and cellular building blocks to perpetuate the rapid growth of tumors.

In the new study, Mischel and his colleagues, including Ludwig postdoctoral fellow Kenta Masui, now an independent researcher in Japan, and Web Cavenee of Ludwig Cancer Research, found that glucose and acetate in turn regulate mTORC2, propelling tumor growth and fending off targeted drugs. "This is a two way street," explains Mischel. "Signaling molecules like mTORC2 can change metabolism, and metabolites can change mTORC2."

The findings first emerged from experiments in glioblastoma cells cultivated in a petri dish. In one experiment, the researchers treated the cells with either glucose or acetate and found that at least one of these nutrients was required in order to turn on mTORC2 in response. The researchers also tested glioblastoma cells with a mutant form of EGFR that turns on mTORC2 and propels tumor growth. In the absence of glucose and acetate, EGFR inhibitors can switch off mTORC2 signaling. But when the researchers added glucose and acetate, the drugs did not work - mTORC2 stayed on and the cells thrived. The researchers delved further, showing how acetate and glucose activate mTORC2 through a molecule formed from these metabolites, acetyl-coA, which is critical for activating a key component of mTORC2.

Together, the experiments show that glucose or acetate can activate mTORC2 through the production of acetyl-coA, enabling tumors to resist targeted therapies such as EGFR inhibitors. Activated mTORC2 in turn propels tumor growth by regulating metabolism and other cellular processes. The researchers provide evidence that a similar mechanism operates in cells taken directly from glioblastoma patients and in human glioblastoma cells implanted into mice.

The findings provide a window into the treatment of glioblastoma, which leaves most newly diagnosed patients with less than two years to live. To reduce deadly brain swelling, many glioblastoma patients require treatment with steroids, which are known to raise blood glucose levels. The new study suggests that the drugs, which may be necessary to control brain swelling, could also have the paradoxical effect of propelling tumor growth through activation of mTORC2. Findings in the study also suggest that developing drugs to effectively target mTORC2 may be one avenue to shutting down glioblastoma and possibly other types of tumors.

"We think this may be a general mechanism in cancer," adds Mischel, who is planning to investigate the role of glucose and acetate in other types of tumors.

The researchers are also beginning to think about how to modify diet in mice to affect the production of these and other metabolites. Mischel notes that the study does not point to the value of any particular diet for counteracting cancer. "How do you turn these findings into something you do for patients? It is going to take diligent and careful work to determine how lifestyle changes, including diet, can alter tumor cell metabolism. We are actively studying this process and hope that this information can be used to develop more effective prevention and treatment strategies for cancer patients."

From a broader perspective, Mischel is intrigued by long-standing arguments among scientists about how much of cancer can be ascribed to environment and how much is random and uncontrollable. The new study suggests that there may be more interplay between genes involved in cancer and the environment than previously thought.

INFORMATION:

In addition to Ludwig Cancer Research, this work is supported by the National Institute for Neurological Diseases and Stroke, the Defeat GBM Research Collaborative, a subsidiary of National Brain Tumor Society, the National Cancer Institute, the Ben and Catherine Ivy Foundation, and donations from the Ziering Family Foundation, the Ichiro Kanehara Foundation, Uehara Memorial Foundation and the Novartis Foundation for the Promotion of Science in Japan.

About Ludwig Cancer Research

Ludwig Cancer Research is an international collaborative network of acclaimed scientists who have been pioneering breakthroughs in cancer research for more than 40 years. Ludwig combines basic research with the ability to translate its discoveries and conduct clinical trials to accelerate the development of new cancer diagnostics and therapies. Since 1971, Ludwig has invested more than $2.5 billion in life-changing cancer research through the not-for-profit Ludwig Institute for Cancer Research and the six U.S.-based Ludwig Centers.

For further information please contact Rachel Steinhardt, rsteinhardt@licr.org or +1-212-450-1582.



ELSE PRESS RELEASES FROM THIS DATE:

Is upward mobility bad for your health?

2015-07-13
Self-control is beneficial for children's school achievement and mental health For low-income youth, self control, and the success it enables, takes a toll on the body Findings have implications for interventions aimed at improving social, racial disparities EVANSTON, Ill. --- Youth from low-income families who succeed academically and socially may actually pay a price -- with their health -- according to a new Northwestern University study. It has been well documented that children from low-income families typically complete less education, have worse health and ...

Fossils indicate human activities have disturbed ecosystem resilience

Fossils indicate human activities have disturbed ecosystem resilience
2015-07-13
CORVALLIS, Ore. - A collection of fossilized owl pellets in Utah suggests that when the Earth went through a period of rapid warming about 13,000 years ago, the small mammal community was stable and resilient, even as individual species changed along with the habitat and landscape. By contrast, human-caused changes to the environment since the late 1800s have caused an enormous drop in biomass and "energy flow" in this same community, researchers reported today in Proceedings of the National Academy of Sciences. The dramatic decline in this energy flow - a measurement ...

Cancer discovery links experimental vaccine and biological treatment

2015-07-13
MADISON, Wis. -- A new study at the University of Wisconsin-Madison has linked two seemingly unrelated cancer treatments that are both now being tested in clinical trials. One treatment is a vaccine that targets a structure on the outside of cancer cells, while the other is an altered enzyme that breaks apart RNA and causes the cell to commit suicide. The study was published July 13 in the new journal of the American Chemical Society: ACS Central Science. The new understanding could help both approaches, says UW-Madison professor of biochemistry Ronald Raines, who ...

Nanoscale light-emitting device has big profile

2015-07-13
MADISON, Wis. -- University of Wisconsin-Madison engineers have created a nanoscale device that can emit light as powerfully as an object 10,000 times its size. It's an advance that could have huge implications for everything from photography to solar power. In a paper published July 10 in the journal Physical Review Letters, Zongfu Yu, an assistant professor of electrical and computer engineering, and his collaborators describe a nanoscale device that drastically surpasses previous technology in its ability to scatter light. They showed how a single nanoresonator can ...

An elusive molecule -- finally revealed

An elusive molecule -- finally revealed
2015-07-13
Scientists at the University of Arizona have discovered a mysterious molecule with a structure simple enough to make it into high school textbooks, yet so elusive that chemists have argued for more than a century over whether it even exists. And, like so many important discoveries in science, this one started out with a neglected flask sitting in a storage fridge, in this case in the lab of Andrei Sanov, a professor in the UA's Department of Chemistry and Biochemistry. Sanov and two of his students report the first definitive observation and spectroscopic characterization ...

Cancers caught during screening colonoscopy are more survivable

2015-07-13
DOWNERS GROVE, Ill. - July 13, 2015 -Patients whose colorectal cancer (CRC) is detected during a screening colonoscopy are likely to survive longer than those who wait until they have symptoms before having the test, according to a study in the July issue of GIE: Gastrointestinal Endoscopy, the monthly peer-reviewed scientific journal of the American Society for Gastrointestinal Endoscopy (ASGE). The study, "Survival in patients with colorectal cancer diagnosed by screening colonoscopy," looked at 312 patients in 10 gastroenterology practices in Germany, all aged 55 or ...

Losing half a night of sleep makes memories less accessible in stressful situations

2015-07-13
It is known that sleep facilitates the formation of long-term memory in humans. In a new study, researchers from Uppsala University, Sweden, now show that sleep does not only help form long-term memory but also ensures access to it during times of cognitive stress. It is well known that during sleep newly learned information is transferred from short-term to long-term memory stores in humans. In the study that is now being published in the scientific journal SLEEP, sleep researchers Jonathan Cedernaes and Christian Benedict, sought to investigate the role of nocturnal ...

Study offers new method of identifying sweet corn hybrids for increased yield and profit

2015-07-13
URBANA, Ill. - Corn hybrids with improved tolerance to crowding stress, grown at higher plant populations than their predecessors, have been a driver of rising field corn yields in recent decades. Large differences in crowding stress tolerance (CST) recently reported among popular sweet corn processing hybrids has growers and processors wondering if newly emerging hybrids also offer improved CST. Martin Williams, a University of Illinois crop scientist and ecologist with the USDA-Agricultural Research Service, said this question is fundamentally important in improving ...

UB researcher explores first-responders' role in end-of-life calls

2015-07-13
BUFFALO, N.Y. - Paramedics and emergency medical technicians (EMTs) are trained to save lives. But they sometimes enter situations where a dying patient's end-of-life wishes contradict their professional code. What do they do when faced with someone who is imminently dying and whose pre-hospital order is "do not resuscitate"? Until recently, the dynamics of that environment were a mystery. "One way to gain perspective on these crises was to interview the paramedics and EMTs involved in them," says Deborah Waldrop, a professor in the University at Buffalo School of Social ...

Antioxidants help treat skin-picking disorder in mice, Stanford researcher says

2015-07-13
Two antioxidant supplements are effective in treating skin-picking disorder in mice, according to a study led by a Stanford University School of Medicine researcher. The finding suggests that people with the potentially serious disorder might benefit from this therapy. An estimated 4 percent of the population -- or about 1 in 25 -- suffer from skin-picking disorder, in which repeated, compulsive picking or scratching of the skin can lead to severe disfigurement and life-threatening infection. Skin picking is also common among laboratory mice, which may develop potentially ...

LAST 30 PRESS RELEASES:

Technical Trials for Easing the (Cosmological) Tension

Mapping plant functional diversity from space: HKU ecologists revolutionize ecosystem monitoring with novel field-satellite integration

Lightweight and flexible yet strong? Versatile fibers with dramatically improved energy storage capacity

3 ways to improve diabetes care through telehealth

A flexible and efficient DC power converter for sustainable-energy microgrids

Key protein regulates immune response to viruses in mammal cells

Development of organic semiconductors featuring ultrafast electrons

Cancer is a disease of aging, but studies of older adults sorely lacking

Dietary treatment more effective than medicines in IBS

Silent flight edges closer to take off, according to new research

Why can zebrafish regenerate damaged heart tissue, while other fish species cannot?

Keck School of Medicine of USC orthopaedic surgery chair elected as 2024 AAAS fellow

Returning rare earth element production to the United States

University of Houston Professor Kaushik Rajashekara elected International Fellow of the Engineering Academy of Japan

Solving antibiotic and pesticide resistance with infectious worms

Three ORNL scientists elected AAAS Fellows

Rice bioengineers win $1.4 million ARPA-H grant for osteoarthritis research

COVID-19 booster immunity lasts much longer than primary series alone, York University-led study shows

Bentham Science joins United2Act

When thoughts flow in one direction

Scientists identify airway cells that sense aspirated water and acid reflux

China’s major cities show considerable subsidence from human activities

Drugs of abuse alter neuronal signaling to reprioritize use over innate needs

Mess is best: disordered structure of battery-like devices improves performance

Skyrmions move at record speeds: a step towards the computing of the future

A third of China’s urban population at risk of city sinking, new satellite data shows

International experts issue renewed call for Global Plastics Treaty to be grounded in robust science

Novel material supercharges innovation in electrostatic energy storage

A common pathway in the brain that enables addictive drugs to hijack natural reward processing has been identified by Mount Sinai

China’s sinking cities indicate global-scale problem, Virginia Tech researcher says

[Press-News.org] Nutrients turn on key tumor signaling molecule, fueling resistance to cancer therapy, Ludwig Cancer Research study shows